Latest news
Is Johnson & Johnson (JNJ) Fully Valued On Darzalex Royalty Strength? - simplywall.stsimplywall.st · Fri, 07 Aug 2026 19:41:15 GMTGenmab (CPSE:GMAB) Stock Revenue Strength Meets Profit Pressure - simplywall.stsimplywall.st · Fri, 07 Aug 2026 18:06:28 GMTGenmab: Q2 beat reinforces the investment story; diversification efforts remain on course - marketscreener.commarketscreener.com · Fri, 07 Aug 2026 13:12:09 GMTAnalyst notes several bright spots in guidance upgrade: "Genmab is focusing on the right areas" - medwatch.commedwatch.com · Fri, 07 Aug 2026 06:11:08 GMTNordea raises its target price for Genmab to 2,083 Danish kroner (2,015), reiterates buy - marketscreener.commarketscreener.com · Fri, 07 Aug 2026 05:29:18 GMTGenmab (GMAB) Q2 2026 Earnings Call Transcript - The Motley FoolThe Motley Fool · Fri, 07 Aug 2026 01:52:00 GMTGenmab AS (GMAB) (Q2 2026) Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo! Finance CanadaYahoo! Finance Canada · Thu, 06 Aug 2026 23:20:17 GMTEarnings call transcript: Genmab lifts 2026 outlook on strong H1 growth, shares slip in Q2 2026 - Investing.com NigeriaInvesting.com Nigeria · Thu, 06 Aug 2026 21:02:03 GMT